In this study, we report that TMPRSS4 confers stem–like properties to prostate cancer cells, mainly through upregulation of SLUG, TWIST1, and SOX2, leading to CTC survival and thereby contributing to metastasis as well as tumorigenicity (Fig. 6I). This evidence concerns the gene SOX2 and prostate cancer.